Formycon AG
XETRA:FYB
Formycon AG
Interest Income Expense
Formycon AG
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Formycon AG
XETRA:FYB
|
Interest Income Expense
€14.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Interest Income Expense
€313.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
121%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Interest Income Expense
€42.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
134%
|
CAGR 10-Years
47%
|
|
CureVac NV
NASDAQ:CVAC
|
Interest Income Expense
€14.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
Immatics NV
NASDAQ:IMTX
|
Interest Income Expense
€4.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Interest Income Expense
-€47.9m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-19%
|
See Also
What is Formycon AG's Interest Income Expense?
Interest Income Expense
14.5m
EUR
Based on the financial report for Dec 31, 2023, Formycon AG's Interest Income Expense amounts to 14.5m EUR.
What is Formycon AG's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
-81%
Over the last year, the Interest Income Expense growth was -81%.